Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
17.59
+0.42 (2.45%)
At close: Oct 9, 2026, 4:00 PM EDT
17.55
-0.04 (-0.23%)
After-hours: Oct 9, 2026, 7:58 PM EDT
Summit Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Maintains $18 → $20 | Hold | Maintains | $18 → $20 | +13.70% | Oct 1, 2026 |
| Jefferies | Jefferies | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 29, 2026 |
| H.C. Wainwright | H.C. Wainwright | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 29, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 29, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $34 | Buy | Maintains | $34 | +93.29% | Sep 29, 2026 |
Unknown Analyst Leerink Partners No rating | Leerink Partners | Hold Reiterates $11 → $13 | Hold | Reiterates | $11 → $13 | -26.09% | Sep 29, 2026 |
| Piper Sandler | Piper Sandler | Hold Maintains $16 | Hold | Maintains | $16 | -9.04% | Sep 29, 2026 |
| UBS | UBS | Buy Maintains $33 | Buy | Maintains | $33 | +87.61% | Sep 29, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.